During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.14 million, with the beta value of the company hitting -1.96. At the end of the trading day, the stock’s price was $6.90, reflecting an intraday gain of 0.73% or $0.05. The 52-week high for the TPST share is $39.00, that puts it down -465.22 from that peak though still a striking 22.46% gain since the share price plummeted to a 52-week low of $5.35. The company’s market capitalization is $28.20M, and the average intraday trading volume over the past 10 days was 0.42 million shares, and the average trade volume was 113.80K shares over the past three months.
Tempest Therapeutics Inc (TPST) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. TPST has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -2.65.
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Tempest Therapeutics Inc (TPST) registered a 0.73% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.73% in intraday trading to $6.90, hitting a weekly high. The stock’s 5-day price performance is -7.63%, and it has moved by 3.60% in 30 days. Based on these gigs, the overall price performance for the year is -81.70%. The short interest in Tempest Therapeutics Inc (NASDAQ:TPST) is 0.11 million shares and it means that shorts have 2.7 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 50.16%. While earnings are projected to return 48.05% in 2025, the next five years will return 22.92% per annum.
TPST Dividends
Tempest Therapeutics Inc is due to release its next quarterly earnings on 2025-May-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Tempest Therapeutics Inc (NASDAQ:TPST)’s Major holders
Tempest Therapeutics Inc insiders own 0.12% of total outstanding shares while institutional holders control 11.74%, with the float percentage being 11.75%. BLACKROCK INC. is the largest shareholder of the company, while 26.0 institutions own stock in it. As of 2024-06-30, the company held over 0.55 million shares (or 2.4405% of all shares), a total value of $1.21 million in shares.
The next largest institutional holding, with 0.43 million shares, is of FMR LLC’s that is approximately 1.9157% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.95 million.
